Spyre Therapeutics, Inc. (SYRE)
73.01
+3.31
(+4.75%)
USD |
NASDAQ |
Apr 17, 16:00
71.32
-1.69
(-2.31%)
After-Hours: 05:22
Spyre Therapeutics SG&A Expense (Quarterly) : 12.53M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 8.33M |
| Replimune Group, Inc. | 18.73M |
| Savara, Inc. | 12.53M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Agios Pharmaceuticals, Inc. | 51.61M |